While the study shows therapeutic effects after intravenous delivery, it's unclear how transplanted mitochondria cross the blood-brain barrier and selectively target affected brain regions. This knowledge gap is essential for developing clinically viable delivery methods and dosing strategies. Gap type: unexplained_observation Source paper: Mitochondrial transplantation exhibits neuroprotective effects and improves behavioral deficits in an animal model of Parkinson's disease. (2024, Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, PMID:38580511)
Landscape Summary: What determines the specificity and efficiency of mitochondrial uptake by different brain cell types in vivo? is a 0.72 priority gap in neurotherapeutics. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
What determines the specificity and efficiency of mitochondrial uptake by different brain cell types in vivo? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No knowledge graph edges recorded
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: